PURPOSE: Continuous intraperitoneal insulin infusion (CIPII) with an implantable pump is safe and effective in selected subjects with diabetes. Our aim was to assess surgical experience and complications with CIPII. METHODS: We performed a retrospective longitudinal observational cohort study of patients that started with CIPII from 1990 to 2006. Operation free period and complication rate were compared between patients initiating CIPII before 2000 and from 2000 onwards. RESULTS: In 63 patients, 166 re-operations were performed during 381 patient-years. Re-operations were pump replacement due to end-of-battery life (47%), laparoscopic catheter-related procedures (29%) and other interventions (24%). Median operation free period increased from 21 to 78 months from 2000 onwards (p = 0.039). Nineteen percent of patients developed complications. No operation-related mortality was reported. CONCLUSIONS: Increased experience together with technical improvements has led to an increase of the operation free period. The absence of procedure-related mortality and a low complication rate makes CIPII feasible for selected patients with diabetes.
PURPOSE: Continuous intraperitoneal insulin infusion (CIPII) with an implantable pump is safe and effective in selected subjects with diabetes. Our aim was to assess surgical experience and complications with CIPII. METHODS: We performed a retrospective longitudinal observational cohort study of patients that started with CIPII from 1990 to 2006. Operation free period and complication rate were compared between patients initiating CIPII before 2000 and from 2000 onwards. RESULTS: In 63 patients, 166 re-operations were performed during 381 patient-years. Re-operations were pump replacement due to end-of-battery life (47%), laparoscopic catheter-related procedures (29%) and other interventions (24%). Median operation free period increased from 21 to 78 months from 2000 onwards (p = 0.039). Nineteen percent of patients developed complications. No operation-related mortality was reported. CONCLUSIONS: Increased experience together with technical improvements has led to an increase of the operation free period. The absence of procedure-related mortality and a low complication rate makes CIPII feasible for selected patients with diabetes.
Authors: L Dufaitre-Patouraux; J P Riveline; E Renard; V Melki; P Belicar-Schaepelynck; J L Selam; B Guerci; L Millot; J M Brun; C Fermon; B Catargi; H Gin; N Jeandidier; P J Lejeune; V Lassmann-Vague Journal: Diabetes Metab Date: 2006-11 Impact factor: 6.041
Authors: Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews Journal: N Engl J Med Date: 2002-03-19 Impact factor: 91.245
Authors: C D Saudek; W C Duckworth; A Giobbie-Hurder; W G Henderson; R R Henry; D E Kelley; S V Edelman; F J Zieve; R A Adler; J W Anderson; R J Anderson; B P Hamilton; T W Donner; M S Kirkman; N A Morgan Journal: JAMA Date: 1996 Oct 23-30 Impact factor: 56.272
Authors: D M Nathan; F L Dunn; J Bruch; C McKitrick; M Larkin; C Haggan; J Lavin-Tompkins; D Norman; D Rogers; D Simon Journal: Am J Med Date: 1996-04 Impact factor: 4.965
Authors: Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski Journal: Transplantation Date: 2016-02 Impact factor: 4.939
Authors: Susan J Logtenberg; Nanne Kleefstra; Sebastiaan T Houweling; Klaas H Groenier; Reinold O Gans; Henk J Bilo Journal: Diabetes Care Date: 2010-02-25 Impact factor: 17.152
Authors: Peter R van Dijk; Susan Jj Logtenberg; Klaas H Groenier; Jan Willem Haveman; Nanno Kleefstra; Henk Jg Bilo Journal: World J Diabetes Date: 2012-08-15
Authors: Peter R van Dijk; Susan J J Logtenberg; Klaas H Groenier; Rijk O B Gans; Nanne Kleefstra; Henk Jg Bilo Journal: BMC Endocr Disord Date: 2014-04-07 Impact factor: 2.763
Authors: Seung Ho Lee; Young Bin Lee; Byung Hwi Kim; Cheol Lee; Young Min Cho; Se-Na Kim; Chun Gwon Park; Yong-Chan Cho; Young Bin Choy Journal: Nat Commun Date: 2017-04-13 Impact factor: 14.919
Authors: Peter R van Dijk; Femke Waanders; Susan J J Logtenberg; Klaas H Groenier; Titia M Vriesendorp; Nanne Kleefstra; Harry van Goor; Henk J G Bilo Journal: Endocrinol Diabetes Metab Date: 2019-08-08